Affinity Asset Advisors, LLC Hedge Fund

Location: New York, NY

CIK: 0001773195 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $358M (91.6% shares, 8.4% debt)

Holdings (64)

SPY SPDR S&P 500 ETF TR 24.9%
Value $89.3M Shares 250,000 Est. Cost Unrealized
ESTA ESTABLISHMENT LABS HLDGS INC 5.0%
Value $17.84M Shares 326,668 Est. Cost $63.72 Unrealized -6.2%
CHINOOK THERAPEUTICS INC 4.5%
Value $16M Shares 813,998 Est. Cost $16.39 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.6%
Value $12.94M Shares 190,000 Est. Cost $68.10 Unrealized
IWM ISHARES TR 3.2%
Value $11.54M Shares 70,000 Est. Cost Unrealized
SNY SANOFI 3.2%
Value $11.41M Shares 300,000 Est. Cost $38.02 Unrealized
TRAVERE THERAPEUTICS INC 3.1%
Value $11.13M Shares 11,000,000 Est. Cost $0.98 Unrealized
ASND ASCENDIS PHARMA A/S 2.9%
Value $10.33M Shares 100,000 Est. Cost $116.37 Unrealized
SNY SANOFI 2.7%
Value $9.505M Shares 250,000 Est. Cost $38.02 Unrealized
KURA KURA ONCOLOGY INC 2.6%
Value $9.231M Shares 675,753 Est. Cost $23.45 Unrealized -34.2%
LNTH LANTHEUS HLDGS INC 2.6%
Value $9.143M Shares 130,000 Est. Cost $42.08 Unrealized +80.0%
INARI MED INC 2.4%
Value $8.717M Shares 120,000 Est. Cost $91.64 Unrealized
NANOSTRING TECHNOLOGIES INC 2.4%
Value $8.544M Shares 10,000,000 Est. Cost $1.02 Unrealized
AZN ASTRAZENECA PLC 2.3%
Value $8.226M Shares 150,000 Est. Cost $61.36 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 1.8%
Value $6.499M Shares 100,000 Est. Cost $80.21 Unrealized -13.4%
VTYX VENTYX BIOSCIENCES INC 1.7%
Value $5.935M Shares 170,000 Est. Cost $22.14 Unrealized 0.0%
POINT BIOPHARMA GLOBAL INC 1.6%
Value $5.771M Shares 746,576 Est. Cost $7.70 Unrealized
AZN ASTRAZENECA PLC 1.5%
Value $5.484M Shares 100,000 Est. Cost $61.36 Unrealized
BELLUS HEALTH INC NEW 1.4%
Value $5.001M Shares 473,597 Est. Cost $5.18 Unrealized
SPRINGWORKS THERAPEUTICS INC 1.4%
Value $4.993M Shares 175,000 Est. Cost $28.53 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 1.4%
Value $4.874M Shares 75,000 Est. Cost $80.21 Unrealized -13.4%
PEN PENUMBRA INC 1.3%
Value $4.74M Shares 25,000 Est. Cost Unrealized
CYMABAY THERAPEUTICS INC 1.3%
Value $4.517M Shares 1,290,511 Est. Cost $3.32 Unrealized
BRIDGEBIO PHARMA INC 1.3%
Value $4.491M Shares 7,500,000 Est. Cost $0.74 Unrealized
BRIDGEBIO PHARMA INC 1.2%
Value $4.437M Shares 10,000,000 Est. Cost $0.47 Unrealized
RCKT ROCKET PHARMACEUTICALS INC 1.2%
Value $4.274M Shares 267,794 Est. Cost $25.12 Unrealized -37.9%
MORPHIC HLDG INC 1.2%
Value $4.146M Shares 146,491 Est. Cost $50.29 Unrealized
ACLX ARCELLX INC 1.1%
Value $3.944M Shares 210,138 Est. Cost $16.91 Unrealized +13.1%
ZNTL ZENTALIS PHARMACEUTICALS INC 1.0%
Value $3.682M Shares 170,000 Est. Cost $39.22 Unrealized -30.3%
ASTRIA THERAPEUTICS INC 1.0%
Value $3.616M Shares 400,043 Est. Cost $9.04 Unrealized
VERONA PHARMA PLC 1.0%
Value $3.577M Shares 350,000 Est. Cost $10.22 Unrealized
ARYA SCIENCES ACQUISITN CORP 1.0%
Value $3.465M Shares 352,500 Est. Cost $9.88 Unrealized
GSK GSK PLC 0.9%
Value $3.237M Shares 110,000 Est. Cost $29.43 Unrealized
CYTK CYTOKINETICS INC 0.9%
Value $3.149M Shares 65,000 Est. Cost $46.31 Unrealized +3.9%
COGT COGENT BIOSCIENCES INC 0.6%
Value $2.299M Shares 154,087 Est. Cost $8.12 Unrealized +68.7%
CLDX CELLDEX THERAPEUTICS INC NEW 0.6%
Value $2.249M Shares 80,000 Est. Cost $32.19 Unrealized -4.7%
GSK GSK PLC 0.6%
Value $2.207M Shares 75,000 Est. Cost $29.43 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.6%
Value $2.147M Shares 136,434 Est. Cost $17.96 Unrealized -12.3%
LNTH LANTHEUS HLDGS INC 0.6%
Value $2.11M Shares 30,000 Est. Cost $42.08 Unrealized +80.0%
VINCERX PHARMA INC 0.6%
Value $2.06M Shares 1,492,771 Est. Cost $13.47 Unrealized
FXE INVESCO CURRENCYSHARES EURO 0.5%
Value $1.809M Shares 20,000 Est. Cost Unrealized
VERONA PHARMA PLC 0.5%
Value $1.687M Shares 165,100 Est. Cost $10.22 Unrealized
GERN GERON CORP 0.4%
Value $1.521M Shares 650,000 Est. Cost Unrealized
PROMETHEUS BIOSCIENCES INC 0.4%
Value $1.475M Shares 25,000 Est. Cost $59.00 Unrealized
GERN GERON CORP 0.4%
Value $1.465M Shares 626,000 Est. Cost Unrealized
PRECIGEN INC 0.4%
Value $1.455M Shares 1,500,000 Est. Cost $0.97 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.4%
Value $1.398M Shares 96,318 Est. Cost $13.98 Unrealized 0.0%
MIST MILESTONE PHARMACEUTICALS IN 0.4%
Value $1.261M Shares 137,200 Est. Cost Unrealized
LIANY LIANBIO 0.3%
Value $1.095M Shares 550,000 Est. Cost $3.37 Unrealized
FXB INVESCO CURRENCYSHARES BRIT 0.3%
Value $1.073M Shares 10,000 Est. Cost Unrealized
CNTX CONTEXT THERAPEUTICS INC 0.3%
Value $981K Shares 883,654 Est. Cost $2.08 Unrealized -13.3%
CNTA CENTESSA PHARMACEUTICALS PLC 0.3%
Value $975K Shares 242,517 Est. Cost $4.02 Unrealized
ALPINE IMMUNE SCIENCES INC 0.2%
Value $792K Shares 110,000 Est. Cost $7.20 Unrealized
NAUT NAUTILUS BIOTECHNOLOGY INC 0.2%
Value $790K Shares 372,476 Est. Cost $10.24 Unrealized -75.4%
VERVE THERAPEUTICS INC 0.2%
Value $687K Shares 20,000 Est. Cost Unrealized
VKTX VIKING THERAPEUTICS INC 0.2%
Value $680K Shares 250,000 Est. Cost $3.28 Unrealized 0.0%
IVERIC BIO INC 0.2%
Value $538K Shares 30,000 Est. Cost Unrealized
KURA KURA ONCOLOGY INC 0.1%
Value $507K Shares 37,100 Est. Cost $23.45 Unrealized -34.2%
IMMATICS N.V 0.1%
Value $507K Shares 187,204 Est. Cost $2.88 Unrealized
RENOVACOR INC 0.1%
Value $503K Shares 199,490 Est. Cost $7.19 Unrealized
TNGX TANGO THERAPEUTICS INC 0.1%
Value $297K Shares 81,982 Est. Cost $4.27 Unrealized 0.0%
VICKERS VANTAGE CORP I 0.0%
Value $17,000 Shares 100,000 Est. Cost $0.17 Unrealized
RENOVACOR INC 0.0%
Value $6,000 Shares 75,000 Est. Cost $0.80 Unrealized
MEDICUS SCIENCES ACQUISITION 0.0%
Value $3,000 Shares 33,333 Est. Cost $1.02 Unrealized